Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.

Flinn IW, Kopecky KJ, Foucar MK, Head D, Bennett JM, Hutchison R, Corbett W, Cassileth P, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson B, Grever MR.

Blood. 2000 Nov 1;96(9):2981-6.

2.

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.

Maloisel F, Benboubker L, Gardembas M, Coiffier B, Divine M, Sebban C, Blanc M, Abgrall JF, Lederlin P, Harousseau JL, Blaise AM, Grosbois B, Morice P, Ghandour C, Castaigne S.

Leukemia. 2003 Jan;17(1):45-51.

PMID:
12529659
3.

Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.

Johnston JB, Eisenhauer E, Wainman N, Corbett WE, Zaentz SD, Daeninck PJ.

Semin Oncol. 2000 Apr;27(2 Suppl 5):32-6.

PMID:
10877049
4.

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

Grever M, Kopecky K, Foucar MK, Head D, Bennett JM, Hutchison RE, Corbett WE, Cassileth PA, Habermann T, Golomb H, et al.

J Clin Oncol. 1995 Apr;13(4):974-82.

PMID:
7707126
6.

Long term outcome of patients with hairy cell leukemia treated with pentostatin.

Ribeiro P, Bouaffia F, Peaud PY, Blanc M, Salles B, Salles G, Coiffier B.

Cancer. 1999 Jan 1;85(1):65-71.

PMID:
9921975
7.

Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.

Golomb HM, Dodge R, Mick R, Budman D, Hutchison R, Horning SJ, Schiffer CA.

Leukemia. 1994 Dec;8(12):2037-40.

PMID:
7807991
8.

Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.

Marotta G, Frassoldati A, Zinzani P, Annino L, Brugiatelli M, Ambrosetti A, Lenoci M, Federico M, Foa R, Lauria F; Italian Cooperative group for HCL (ICGHCL).

Eur J Haematol. 2006 Aug;77(2):109-13.

PMID:
16856905
9.

Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.

Dearden CE, Matutes E, Hilditch BL, Swansbury GJ, Catovsky D.

Br J Haematol. 1999 Aug;106(2):515-9.

PMID:
10460614
10.

Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.

Bastie JN, Cazals-Hatem D, Daniel MT, D'Agay MF, Rabian C, Glaisner S, Noel-Walter MP, Dabout D, Flandrin G, Dombret H, Poisson D, Degos L, Castaigne S.

Leuk Lymphoma. 1999 Nov;35(5-6):555-65.

PMID:
10609793
11.

Pentostatin induces durable remissions in hairy cell leukemia.

Cassileth PA, Cheuvart B, Spiers AS, Harrington DP, Cummings FJ, Neiman RS, Bennett JM, O'Connell MJ.

J Clin Oncol. 1991 Feb;9(2):243-6.

PMID:
1988572
12.

Pentostatin in the treatment of hairy-cell leukemia.

Grever MR, Doan CA, Kraut EH.

Best Pract Res Clin Haematol. 2003 Mar;16(1):91-9. Review.

PMID:
12670468
13.

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.

Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O'Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D.

Br J Haematol. 2009 Jun;145(6):733-40. doi: 10.1111/j.1365-2141.2009.07668.x. Epub 2009 Mar 29.

PMID:
19344416
14.
15.

Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).

López Rubio M, Da Silva C, Loscertales J, Seri C, Baltasar P, Colado E, Pérez Fernández I, Osma M, Gomis F, González M, Jarque I, Vargas M, Monzó E, Monteagudo D, Orts MI, Pardal E, Carbonell F, Perez Calvo C, Garcia-Marco JA.

Leuk Lymphoma. 2014 May;55(5):1007-12. doi: 10.3109/10428194.2013.827187. Epub 2013 Sep 16.

PMID:
23885799
16.

Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.

Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.

Semin Oncol. 2000 Apr;27(2 Suppl 5):52-7.

PMID:
10877053
17.

Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.

Goodman GR, Burian C, Koziol JA, Saven A.

J Clin Oncol. 2003 Mar 1;21(5):891-6.

PMID:
12610190
18.

Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.

Saven A, Burian C, Koziol JA, Piro LD.

Blood. 1998 Sep 15;92(6):1918-26.

19.

[Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].

Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.

Srp Arh Celok Lek. 2000 Jul-Aug;128(7-8):262-70. Serbian.

PMID:
11089434
20.

Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.

Else M, Ruchlemer R, Osuji N, Del Giudice I, Matutes E, Woodman A, Wotherspoon A, Swansbury J, Dearden C, Catovsky D.

Cancer. 2005 Dec 1;104(11):2442-8.

Supplemental Content

Support Center